Showing 1 - 10 of 7,842
Background : There are limited data available on the economical burden of psoriasis and its impact on everyday life. Objective : The aim of this study was to evaluate the impact of psoriasis on personal and professional life, and to evaluate the cost of psoriasis for the patient. Methods : We...
Persistent link: https://www.econbiz.de/10011166484
Persistent link: https://www.econbiz.de/10010707081
Persistent link: https://www.econbiz.de/10010708719
Objectives To compare prices of new drugs between France and the other EU4. Methods Study used IMS MIDAS database for economic data such as prices and sales volume and LEEM database (French association of the pharmaceutical manufacturers) for the ASMR scale (HAS assessment of the drug’s added...
Persistent link: https://www.econbiz.de/10011073636
Background: To compare the daily costs of 3 prostaglandin analogues (bimatoprost, latanoprost, travoprost), alone, and associated with timolol in 4 European countries (Denmark, Finland, Germany, and Sweden). Methods: Six glaucoma products were sampled by buying 5 bottles from 1 suburban pharmacy...
Persistent link: https://www.econbiz.de/10011072247
Persistent link: https://www.econbiz.de/10010861406
Persistent link: https://www.econbiz.de/10010861439
Persistent link: https://www.econbiz.de/10010861586
Introduction : Benefit-risk of different anti-rabies post-exposure prophylaxis (PEP) strategies after scratches or bites from dogs with unknown rabies status is unknown in very low rabies risk settings. Design and setting : A cost-effectiveness analysis in metropolitan France using a...
Persistent link: https://www.econbiz.de/10011212046
The recently published "Survival and Ventricular Enlargement" (SAVE), prospective controlled trial over 4 years including over 2,000 patients, has shown that long-term treatment with captopril reduced cardiovascular mortality (- 19%) and morbidity in patients with post-infarction left...
Persistent link: https://www.econbiz.de/10011265513